Annual report pursuant to Section 13 and 15(d)

BUSINESS AND RECAPITALIZATION (Details Narrative)

v3.7.0.1
BUSINESS AND RECAPITALIZATION (Details Narrative)
12 Months Ended
Dec. 31, 2016
Jul. 28, 2016
State of Incorporation Nevada  
BioCorRx Pharmaceuticals, Inc [Member] | BioCorRx, Inc [Member]    
Equity issued ownership   78.10%
Officer [Member] | BioCorRx Pharmaceuticals, Inc [Member]    
Equity issued ownership   21.90%